MEDIGENA

MEDIGENA has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30,000 and a net result of €14,379. Equity is shrinking by ~2.9% per year across the filed fiscal years. Its solvency ranks better than 11% of 20346 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).